Searched for
ORBIMED ASIA
Nutrition brand TruNativ closes $30 million round with OrbiMed Advisors LLCClean-label nutrition brand TruNativ has secured $30 million from OrbiMed Advisors LLC to boost distribution, expand its product range, and...- Dental products firm Laxmi Dental gets Sebi's go ahead to float IPOLaxmi Dental Ltd has received approval from Sebi for its IPO, comprising a fresh issue of ₹150 crore and an OFS of 1.28 crore shares. Proce...
- Laxmi Dental files draft papers to raise funds via IPODental products company Laxmi Dental Ltd has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial...
- General Atlantic, other PE funds in talks for majority stake in AIMSGeneral Atlantic and KKR are among several private equity firms vying for a majority stake in Faridabad-based Asian Institute of Medical Sc...
- OrbiMed-backed Suraksha Diagnostic files IPO papersOrbiMed-backed Suraksha Diagnostic has filed the draft red herring prospectus (DRHP) with capital markets regulator SEBI to float an initia...
- Entero Healthcare shares to list on Friday. What GMP signals ahead of D-St debutIn the unlisted market, the company's shares are trading with a marginal premium of Rs 2, which indicates a flat or even a discounted debut...
- Arcatron Mobility raise growth capital from OrbiMed, a global healthcare-focused investment firmArcatron Mobility has raised growth capital from OrbiMed, a global healthcare-focused investment firm. The funds will be used to increase R...
- Entero Healthcare's Rs 1,600-cr IPO biggest so far in 2024: 10 things to know before subscribing to the issueThe IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares. Under the OFS, Prabhat Agrawal, ...
- Entero Healthcare announces dates, price band for its Rs 1,600-cr IPOEntero Healthcare IPO: The price band has been fixed in the range of Rs 1,195-1,258 per equity share. Bids can be made for a minimum of 11 ...
- Sebi gives nod for four IPOsHealthcare products distributors Entero Healthcare's IPO consists of a fresh issue of ₹1,000 crore and an offer for sale of 85.57 lakh shar...
- Entero gets Sebi nod for IPOThe Company’s initial public offering comprises a fresh issue of up to Rs 1000 crore and an offer for sale of up to 8,557,597 equity shares.
- Innvolution secures growth capital from OrbiMed to advance R&D, expand product line and enter global marketsInnvolution has recently received substantial growth capital from OrbiMed, an investment firm dedicated to healthcare
- Marksans Pharma hits upper circuit as company considers preferential allotmentShares of Marksans Pharma rallied 20 per cent, its upper circuit limit, to Rs 83.70 on Friday. However the counter was trading at Rs 81.75 ...
- Carlyle-Zydus and Advent join race to acquire Bharat Serums and Vaccines LtdThey are up against domestic pharma companies Dr Reddy's Labs, Mankind & Goldman Sachs which have also made offers.
- Domestic pharmaceutical players eye Bharat Serums acquisitionThe two funds together hold a 23% stake and the remainder is with the Daftary family.
- Vivimed Labs gets additional $7.5 million funding from OrbiMed AsiaThe company had earlier received USD 42.5 million from OrbiMed Asia in September 2017, Vivimed Labs said in a BSE filing.
- Netmeds raises $14 million from Tanncam, Sistema Asia FundTanncam and Sistema will join early investors investment bank MAPE and OrbiMed Asia, along with Pradeep Dadha and his family, as stakeholde...
- Beams Hospitals in talks with PE investors to raise $20 millionThere is a sharp increase in the flow of risk capital to the healthcare sector in the past year driven by growing demand for quality servic...
- Shasun Pharma to invest Rs 250 crore in expansion next fiscalThe company has received approval to raise Rs 50 crore through preferential allotment of shares to Caduceus Asia Mauritius
- Shasun Pharmaceuticals to sell 11.93 stake to US firm OrbiMed for Rs 50 croreShasun Pharmaceuticals said its board has approved to sell 11.93 per cent stake to US- based healthcare investment firm OrbiMed for Rs 50 c...
Load More
